Paracoccidioidomycosis classification

	Paracoccidioidomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paracoccidioidomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Paracoccidioidomycosis classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paracoccidioidomycosis classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paracoccidioidomycosis classification
CDC on Paracoccidioidomycosis classification
Paracoccidioidomycosis classification in the news
Blogs on Paracoccidioidomycosis classification
Directions to Hospitals Treating Paracoccidioidomycosis
Risk calculators and risk factors for Paracoccidioidomycosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac

Overview

Paracoccidioidomycosis may be classified based on the onset and duration of symptoms. Paracoccidioidomycosis may be classified into: acute, subacute or chronic. The chronic form can be further subclassified into: unifocal and multifocal.^[1]^[2]

Classification

Latent paracoccidioides infection^[2]^[3]

Patients have no clinical manifestations
Positive reaction to the paracoccidioidin skin test

Paracoccidioides disease

Acute form (Juvenile)
- Usually affects patients under 35 years
Chronic form (Adult)
- Unifocal: Affects one organ or system
- Multifocal: Affects two or more organs or systems

Residual form (Sequela)

Most frequently, chronic pulmonary obstructive disease

References

↑ de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F; et al. (2015). "Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis". Front Microbiol. 6: 1319. doi:10.3389/fmicb.2015.01319. PMC 4658449. PMID 26635779.
↑ ^2.0 ^2.1 Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.
↑ Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. An. Bras. Dermatol.2013;88(5):700-711

[pmid26635779-1] Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F; et al. (2015). "Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis". Front Microbiol. 6: 1319. doi:10.3389/fmicb.2015.01319. PMC 4658449. PMID 26635779.

[pmid21738969-2] 2.0 ^2.1 Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.

[eee-3] Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. An. Bras. Dermatol.2013;88(5):700-711

[1]

[2]

[3]